Franklin Resources’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.5M Buy
137,871
+61,429
+80% +$5.44M ﹤0.01% 1095
2025
Q4
$6.68M Sell
76,442
-6,476
-8% -$530K ﹤0.01% 1289
2025
Q3
$5.51M Buy
82,918
+339
+0.4% +$19.3K ﹤0.01% 1386
2025
Q2
$4.56M Buy
82,579
+3,535
+4% +$170K ﹤0.01% 1395
2025
Q1
$3.82M Sell
79,044
-9,826
-11% -$412K ﹤0.01% 1441
2024
Q4
$3.43M Buy
88,870
+7,279
+9% +$317K ﹤0.01% 1519
2024
Q3
$3.78M Buy
81,591
+45,674
+127% +$1.85M ﹤0.01% 1477
2024
Q2
$1.24M Buy
35,917
+4,073
+13% +$119K ﹤0.01% 1850
2024
Q1
$921K Buy
+31,844
New +$866K ﹤0.01% 1988
2023
Q4
Sell
-11,853
Closed -$198K 2700
2023
Q3
$198K Sell
11,853
-29,231
-71% -$567K ﹤0.01% 2324
2023
Q2
$1.13M Buy
41,084
+8,551
+26% +$214K ﹤0.01% 1596
2023
Q1
$2.29M Buy
32,533
+17,785
+121% +$299K ﹤0.01% 1324
2022
Q4
$161K Buy
+14,748
New +$124K ﹤0.01% 2047

Other funds holding PTGX